[Federal Register Volume 64, Number 175 (Friday, September 10, 1999)]
[Notices]
[Page 49203]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 99-23564]
[[Page 49203]]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institutes of Allergy and Infectious Diseases; Notice of
Closed Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act as
amended (5 U.S.C. Appendix 2), notice is hereby given of the following
meeting.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The contract proposals and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the contract proposals, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Institute of Allergy and Infectious
Diseases Special Emphasis Panel HIV Vaccine Design and Development
Teams.
Date: October 20-21, 1999.
Time: 8:30 AM to 5:30 PM.
Agenda: To review and evaluate contract proposals.
Place: Holiday Inn Bethesda, Maryland Room, 8120 Wisconsin
Avenue, Bethesda, MD 20814.
Contact Person: Kevin W. Ryan, PhD, Scientific Review
Administrator, Scientific Review Program, Division of Extramural
Activities, NIAID, NIH, Room 2217, 6700-B Rockledge Drive, MSC 7610,
Bethesda, MD 20892-7610, 301-496-2550.
(Catalogue of Federal Domestic Assistance Program Nos. 93.855,
Allergy, Immunology, and Transplantation Research, 93.856,
Microbiology and Infectious diseases Research, National Institutes
of Health, HHS)
Dated: August 31, 1999.
LaVerne Y. Stringfield,
Director, Office of Federal Advisory Committee Policy, NIH.
[FR Doc. 99-23564 Filed 9-9-99; 8:45 am]
BILLING CODE 4140-01-M
